The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1β (IL-1β), and tissue inhibitor of metalloproteinase-1 (TIMP- 1) gene expression during the development of osteoarthritis

Osteoarthritis and Cartilage

Volumn 7, Issue 2, 1999, Pages 182-190

  Takahashi, Kenji ^a   Goomer, Randal S ^a   Harwood, Fred ^a   Kubo, Toshikazu ^b   Hirasawa, Yasusuke ^b   Amiel, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cytokine; Hyaluronan; Matrix metalloproteinase; Osteoarthritis

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 1BETA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME REGULATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM;

EID: 0033103062     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0207     Document Type: Article

References (31)

1. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
2. Pelletier JP, Martel-Pelletier J, Malemud CJ. Canine osteoarthritis: Effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycans. J Orthop Res 1988;6:379-88.
3. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986;261:14,245-55.
4. Wu J-J, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen type II, IX, X, and XI of cartilage. J Biol Chem 1991;266:5625-8.
5. Dean DD, Woessner JF. Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases. Biochem J 1984;218:277-80.
6. Pelletier J-P, Mineau F, Faure M-P, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33:1466-76.
7. Pelletier JP, Martell-Pelletier J. Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation. Protective effects of nsaids. J Rheumatology 1989;16:19-27.
8. Pelletier JP, Faure MP, Dibattista JA, Wilhelm S, Viscos D, Martell-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1 and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 1993;142:95-105.
9. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
10. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin 1: Comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6.
11. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans E. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
12. Rediske JJ, Koehne CF, Zhang B, Lotz M. The inducible production of nitric oxide by articular cell type. Osteoarthritis Cart 1994;2:199-206.
13. Blanco JF, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
14. Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D. The effects of hyaluronam during the development of osteoarthritis. Osteoarthritis Cart 1997;5:251-60.
15. Shimizu C, Yoshioka M, Coutts RD, Harwood FL, Kubo T, Hirasawa Y, et al. Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee. Osteoarthritis Cart 1998;6:1-9.
16. Kikuchi T, Denda S, Yamaguchi T. Effect of sodium hyaluronate (SL-1010) on glycosaminoglycan synthesis and release in rabbit articular cartilage. Jap Pharcol Ther 1993;127:157.
17. 2 production in human osteoarthritic synovial cells. Agents Actions 1992;37:155-6.
18. 14c] arachidonic acid release from labeled human synovial fibroblasts. Jap J Pharmacol 1992;60:79-84.
19. Yoshioka M, Coutts RD, Amiel D, Hacker SA. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthritis Cart 1996;4:87-98.
20. Chomcznski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Chang DG, Iverson EP, Schinagl RM, Sonoda M, Amiel D, Coutts RD, Sah RL. Quantitation and localization of cartilage degeneration following the induction of osteoarthritis in the rabbit knee. Osteoarthritis Cart 1997;5:357-72.
22. Fini ME, Karmilowicz MJ, Ruby PL, Beeman AM, Borges KA, Brinckerhoff CE. Cloning of a complementary DNA for rabbit proactivator: A metalloproteinase that activates synovial cell collagenase shares homology with stromelysis and transin, and is coordinately regulated with collagenase. Arthritis Rheum 1987;30:1254-64.
23. Cannon JG, Clark BD, Wingfield P, Schmeissner U, Losberger C, Dinarello CA, et al. Rabbit IL-1: Cloning, expression, biologic properties, and transcription during endotoxemia. J Immunol 1989;142:2299-306.
24. Horowitz S, Dafni N, Shapiro DL, Holm BA, Notter RH, Quible DJ. Hyperoxic exposure alters gene expression in the lung: Induction of the tissue inhibitor of metalloproteinases mRNA and other mRNAs. J Biol Chem 1989;264:7092-5.
25. Harris De, Warshaw DM, Periasamy M. Nucleotide sequences of the rabbit a-smooth-muscle and b-non-muscle actin mRNAs. Gene 1992;112:265-6.
26. Zafarullah M, Pelletier J-P, Cloutier J-M, Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatology 1993;20:693-7.
27. Yasui T, Akatsuka M, Tobetto K, Umemoto J, Ando T, Yamashita K, et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-8.
28. Sakamoto T, Mizuno S, Maki T, Suzuki K, Yamaguchi T, Iwata H. Studies on the affinity of hyaluronic acid to the surface of articular cartilage and the suppression of proteoglycan release from matrix. Orthopaedic Research Science (in Japanese) 1984;11:264.
29. Van Wart HE, Birkedal-Hansen H. The cystein switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinage gene family. Proc Nat Acad Sci USA 1990;87:5578-82.
30. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
31. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C. The hyaluronate receptor is a member of the CD44 (HCAM) family of cell surface glycoproteins. J Cell Biol 1990;111: 2765-74.